Javascript is currently disabled in your browser. Several features of this site will not function whilst javascript is disabled.
open access to scientific and medical research
From submission to first editorial decision.
From editorial acceptance to publication.
The a
Full disclosure: I get lip fillers. I love them. I started getting them a year ago after a friend of mine got hers done and they looked amazing. I also think if you want to get something done to your face, hair, or your body you should go ahead and do it because it’s your right.
Howeve
Click here to sign in with or
A beautician has revealed how she spent £5,000 turning herself into a ‘Barbie’ – but hated it when she could no longer recognise herself.
And now she refuses to give her own clients filler if she can’t see the benefit.
Emily Spence became addicted to dermal fillers when s
According to the Astute Analytica study on the global Hyaluronic Acid Market, the size of the market will increase from US$ 7.94 Bn in 2021 to US$ 20.01 Bn by 2030, registering a remarkable compound annual growth rate (CAGR) of 11.53% from 2022 to 2030.
The s
--Results from the PROGRESS Phase 3 trial on atogepant for the preventive treatment of chronic migraine will be showcased as an oral presentation
--Breadth of research underscores AbbVie's leadership and commitment to people living with migraine
ABBVie (NYSE: ABBV) today an
Allergan Aesthetics Korea said it has identified four key themes that will drive consumer behavior change in the global aesthetics market. The four key themes are beauty empowerment, aesthetic fluency, untabooing treatments, and a desire to move back to nature.
The company has published
An FDA inspection found several issues including spore-related contamination in the manufacturing area at a site in the city of Chuncheon, South Korea.
The inspection took p
Just when you thought you had the perfect skincare routine down pact, a new viral product or trend emerges from TikTok to prove you wrong. What has BeautyTok users in a frenzy now: injectable moisturizers.
Known professionally in clinics as Profhilo, the specially formulated injectable m
Approved label includes full 36-week efficacy data from Phase 3 SAKURA clinical program, positioning DAXXIFY™ as the first and only long-acting neuromodulator that demonstrates a median duration of six months and up to nine months for some patients1- 6* ‡
Based on the data from SAKUR